Jump to navigation Jump to search
Napa Therapeutics, Ltd is a biotech company researching ways to increase cellular levels of NAD+, a substance that depletes with age. The company was created from a partnership between the Buck Institute and Juvenescence.
- "Napa Therapeutics, Ltd." Juvenescence. Retrieved 8 May 2021. "Napa Therapeutics, Ltd. is a discovery-stage company focused on NAD+ metabolism. There is ample evidence that NAD+ depletion is a key feature of aging. Napa’s core IP will surround a novel target within NAD+ metabolism to increase levels of NAD+ within the tissue. [...] Napa Therapeutics is a spinout from The Buck Institute for Research on Aging partnering with Juvenescence."
- "Napa Therapeutics". Longevity List. Retrieved 8 May 2021. "Drug that increases NAD+ levels"